Skip to main content
Acta Clinica Croatica logoLink to Acta Clinica Croatica
. 2024 Dec;63(3-4):656–661. doi: 10.20471/acc.2024.63.03-04.25

RHEOLOGICAL PARAMETERS OF CAROTID CIRCULATION IN METABOLIC SYNDROME WITH OR WITHOUT DIABETES MELLITUS

Alen Hajdarević 1, Dragan Piljić 1,✉, Fahrudin Šabanović 2, Dilista Piljić 1, Farisa Babić 2, Ajdin Beganović 3, Juš Kšela 4
PMCID: PMC12490446  PMID: 41050261

SUMMARY

The aim of this research was to examine the rheological parameters of carotid arteries and the frequency of abnormal values in patients with metabolic syndrome (MetS) with and without diabetes mellitus (DM). The sample consisted of 90 subjects and was divided into two equal groups. The first group consisted of patients with MetS but without DM, while the second group had both MetS and DM. We used the values of the peak systolic velocity (PSV) as a reference for pathology. The results showed pathological values of PSV in the right internal carotid artery (ICA) in twelve patients in the MetS + DM group. The study found that the incidence of pathological rheological parameters was higher in subjects with MetS + DM as compared to those with only MetS. Subjects with MetS + DM had higher values of maximum acceleration during systole in various carotid arteries. A subject with MetS + DM also showed total flow obstruction in the left and internal carotid artery (ICA) and a severe narrowing of the right ICA, indicating the presence of carotid artery disease. The study also found that nearly two-thirds of subjects with MetS + DM had pathological values of PSV in the right ICA and slightly fewer in the left ICA. Research on French populations has shown similar results. Eleven patients had pathological values in the left ICA. The frequency of the carotid rheological parameters’ abnormalities was significantly higher in the MetS with DM patient group. The frequency of abnormalities in the rheological parameters of carotid circulation was significantly higher in patients with MetS and DM (as compared to non-diabetic patients). In our study, pathological changes were generally more susceptible to ICA. This indicates the importance of screening the rheological parameters of subjects with MetS for the prevention and treatment of cerebrovascular disease.

Keywords: Rheological parameters, Carotid occlusive disease, Metabolic syndrome, Carotid circulation, Diabetes mellitus type 2

Introduction

Metabolic syndrome (MetS) is a risk factor for cardiovascular disease and type 2 diabetes due to the existence of abdominal obesity and insulin resistance (1). Vascular pathologies are very common in patients with MetS, especially in those who also have diabetes mellitus (DM). As a result of the vascularization of important organs, the head and neck carotid arteries and their disease are important clinical entities. The criterion for diagnosing MetS varies significantly between various professional societies.

According to the guidelines of the National Cholesterol Education Program – Adult Treatment Panel III (NCEP-ATP III), obesity is defined as the most important criterion for the diagnosis of MetS (defined as waist size>102cm for men and >88cm for women). The other criteria for establishing metabolic syndrome include:

  • hyperlipoproteinemia (triglycerides ≥1.69 mmol/L or high-density lipoprotein concentrations ≤1.04 mmol/L for men and ≤1.29 mmol/L for women);

  • Hypertension (systolic ≥130mmHg or diastolic ≥85 mmHg); and

  • hyperglycemia (fasting glucose concentration in blood glucose ≥5.6 mmol/L)

The presence of obesity (defined by waist size) and two other components is sufficient for diagnosing MetS. If obesity is not present, all three of the above components must be present for a diagnosis of MetS (2-4). DM is a systemic metabolic disorder that is chara- cterized by permanently elevated glucose levels in the blood. Hereditary factors causing reduced secretion and/or reduced effects of the hormone insulin are mainly responsible for developing DM. This discrepancy in secretion or acting interferes with the metabolism of carbohydrates, fats, and proteins in the body and, in the long term, affects the structure and function of blood vessels, nerves, and other vital organ systems (5, 6).

Carotid disease in patients with MetS usually manifests as atherosclerotic stenosis and occlusion (7).

Subjects and Methods

This study sought to determine the rheological parameters of carotid arteries in subjects with MetS, diagnosed within the past five years, with or without DM.

The study was approved by the Ethics Committee of the University Clinical Center Tuzla, Bosnia and Herzegovina. This prospective observational-comparative study was performed at the Department for Cardiovascular Diseases – University Clinical Center Tuzla, and 90 patients were enrolled.

Patients

MetS diagnosis was made utilizing NCEP-ATP III criteria2. The recruitment of patients was based on the following available medical history data: information on DM, the results of anthropometric measurements (waist size), values of blood pressure, and laboratory tests (serum triglycerides and high-density lipoproteins).

In addition to history, we used an oral glucose tolerance test to surely differentiate whether a patient with MetS also suffers from DM. Afterward, we divided the patients into two groups: 1) patients with MetS and normal glucoregulation and 2) patients with MetS and abnormal glucoregulation (Table 1).

Table 1. Study groups.

First group (MetS with normal glucoregulation) Second group (MetS with abnormal glucoregulation)
   Sex 45 patients: 27 male, 18 female 45 patients: 35 male, 10 female
Age (Years) 63.4 (44-77) ± 8.7 64.2 (52-76) ± 6.2
Blood sugar measured fasting (mmol/L) 5.7 (9.2-4.1) 8.2 (14.2-5.1)
Waist circumference (cm) 90.1 (121-76) 100.3 (135-81)
Blood pressure (mmHg) 125.8 (170-95) / 80 (100-55) 133.7 (170-110) / 82.6 (100-55)
High-density lipoproteins (mg/ dL) 1.1 (1.5-0.8) 0.9 (1.4-0.7)
Triglycerides (mmol/L) 2.6 (4.9-1.5) 2.5 (4.5-1.3)

MetS = metabolic syndrome

The exclusion criteria were as follows: patients with diabetes mellitus type 1; patients who had surgery or injury to deeper tissues and/or who had a tumor process localized in the areas of carotid arterial delivery; and patients with hereditary or autoimmune disease with vascular symptoms.

Outcome measure

The extent of atherosclerotic disease on the carotid artery was determined by color Doppler ultrasonography, and stenosis was primarily diagnosed using pulse wave section measuring values of peak systolic velocity (PSV) on the common carotid artery (CCA), external carotid artery (ECA), and internal carotid artery (ICA). When there was no flow and no PSV, we considered this to be an occlusion and confirmed it secondarily by the morphological characteristics of the blood vessels. Doppler ultrasonography was performed according to standard procedure: at room temperature, in a horizontal position by the side of the patient, and with Siemens (SONOLINE G60S, 2003) linear probes (7.5 mHz).

Statistics

In addition to standard descriptive statistical methods, the statistical analysis was conducted using the Mann-Whitney U test8. The normality of the data was assessed using the Kolmogorov-Smirnov goodness-of-fit test. We conducted a chi-square test to determine if there was a statistical difference between the two groups.

A significance level of 5% was applied, while the analyses were performed using Microsoft Office Excel 2007 and the Arcus Quickstat Biomedical program for statistical data processing.

Results

Table 2 shows the measured PSV of carotid arteries at all sites (CCA, ICA, ECA) for both groups, a total of 90 patients, and includes calculated median values.

Table 2. PSV parameters of CCA, ICA and ECA in the two study groups.

                  MetS only                  MetS+DM p
Artery    Median    Min    Max    Median    Min    Max
ACC dex    60    40    90    70    40    80    0.1918
ACI dex    80    50    240    110    60    270    0.0015
ACE dex    80    50    180    80    60    170    0.3089
ACC sin    60    40    90    60    40    90    0.6553
ACI sin    90    60    220    110 0    240    0.4137
ACE sin    70    60    200    80    60    120    0.3399

PSV = peak systolic velocity – values are expressed in cm/s; CCA = common carotid artery; ICA = internal carotid artery;

ECA = external carotid artery; MetS = metabolic syndrome; DM = diabetes mellitus; ACC dex = right common carotid artery (Latin: arteria carotis communis dextra); ICA dex = right internal carotid artery (Latin: arteria carotis interna dextra); ACE dex = right external carotid artery (Latin: arteria carotis externa dexter); ACC sin = left common carotid artery (Latin: arteria carotis communis sinistra); ICA sin = left internal carotid artery (Latin: arteria carotis interna sinistra); ACE sin = left external carotid artery (Latin: arteria carotis externa sinistra); Min = minimum; Max = maximum;

Table 2 compares the median, minimum, and maximum values of rheological parameters (ACC dex., ICA dex., ACE dex., ACC sin., ICA sin., and ACE sin.). This comparison is made for the two groups of patients: those with MetS only and those with both MetS and DM. The p-values are also given for each rheological parameter to indicate the level of significance between the two groups.

For example, for the rheological parameter ACC dex., the median value for the group with MetS only is 60, and the minimum value is 40. The maximum value is 90. The median value for the group with MetS + DM is 70, and the minimum value is 40. The maximum value is 80. The p-value for this parameter is 0.1918, indicating that the difference between the two groups is not significant (p>0.05).

Similarly, for ICA dex., the median value for the group with MetS only is 80, and the minimum value is 50. The maximum value is 240. The median value for the group with MetS + DM is 110, with a percentile range of 90 to 140, and a minimum value of 60. The maximum value is 270. The p-value for this parameter is 0.0015, indicating that the difference between the two groups is significant (p<0.05).

Distribution of pathological results in the groups

A distribution of pathological results refers to the distribution or spread of abnormal or pathological values found in different groups. In this context, the groups are patients with MetS only and patients with both MetS and DM. By analyzing the distribution of pathological results, we can understand the frequency and pattern of abnormality in each group and determine whether there are any significant differences between the two groups. By comparing the distributions, we draw conclusions about the relationship between MetS, DM, and the pathological results of the rheological parameters of the carotid arteries. There are significant differences between MetS and MetS + DM (chi-square test, see Table 3).

Table 3. Distribution of PSV pathologic findings in subjects with MetS only and subjects with MetS + DM.

Parameter of variable      χ2
Maximum speed flow of blood in systole (PSV) Right internal carotid artery    <0.0001
Right external carotid artery    0.2941
Left internal carotid artery    0.1405
Left external carotid artery    0.2235

PSV = peak systolic velocity; MetS = metabolic syndrome; DM = diabetes mellitus

As we can see from Table 2, there is a significant difference between the ICA on the right side (χ2<0.0001), while the same cannot be said for the ECA on the right side (χ2=0.2941). We cannot say that there is a significant difference in the carotid arteries on the left side.

Rheological parameters in subjects with non-diabetic metabolic syndrome

The results of the MetS-only subjects have shown the presence of some pathological values of PSV of the right ICA in almost one-third of cases (30.0%), while the same group of thirteen subjects (43.3%) had abnormal values of PSV in the left ICA.

Five subjects with MetS were found to have some pathological values of PSV in the right ACE (16.6 %). Three respondents (10.0%) in the same group had pathological values in the left ACE.

As a result of the pathological measurements obtained at the ICA and ACE in subjects with MetS alone, we extrapolate the significant impact of MetS on cardiovascular disease. Several studies have established the connection between MetS and an increased risk of cardiovascular disease (8–10).

Hence, there is an association between MetS and disorders of carotid circulation. Of course, we cannot exclude age as an independent factor contributing to this disorder. This study, however, was unable to estimate this, due to limited number of cases.

In the prospective Bruneck study, subjects with MetS had a more rapid progression of carotid artery disease by forming atherosclerotic plaques and consequent luminal narrowing (9).

The study found that the incidence of pathological rheological parameters was higher in subjects with MetS + DM compared to those with only MetS. Subjects with MetS + DM had higher values of maximum acceleration during systole in various carotid arteries. A subject with MetS + DM also showed total flow obstruction in the left ICA and a severe narrowing of the right ICA, indicating the presence of carotid artery disease. The study also found that nearly two-thirds of subjects with MetS + DM had pathological values of PSV in the right ICA and slightly fewer in the left ICA. Research of French populations has shown similar results.

Discussion

Detecting vascular pathologies at an early stage via color Doppler ultrasonography can significantly contribute to the treatment and prevention of their complications, especially if recent reports indicate that there is no significant difference in the results obtained using CDUs and CTAs (11). The progression of these complications has negative repercussions on the quality of life of patients and highlights the importance of their early detection and treatment.

When determining disease severity, the role of fast and inexpensive ultrasound diagnostics should not be underestimated. Some studies on color duplex ultrasonography have shown sensitivity of 90-96% and specificity of 86-93% (8).

MetS is a common condition that is associated with an increased risk of developing cardiovascular disease (12). In our study of 90 patients with MetS, we found that males were predominant, accounting for 68.3% of the sample. This is consistent with previous studies of French and German populations, which also found a higher prevalence of MetS in men.

We also found that the highest median values of PSV were recorded in the right and left ICAs. This suggests that these arteries may be particularly affected by the vascular complications associated with MetS.

Interestingly, we found that the prevalence of MetS in female patients was similar to that in Spain and Italy, countries with populations at high cardiovascular risk. This highlights the need for early detection and treatment of MetS in both men and women, to prevent the negative consequences of this condition on cardiovascular health.

Conclusion

In conclusion, our study shows that the presence of both MetS and DM results in a higher incidence of pathological rheological parameters compared to having MetS alone. These findings emphasize the importance of early detection and monitoring of cardiovascular risk factors in individuals with MetS and DM. The use of ultrasound as a diagnostic tool in such cases can provide valuable information for the management of these conditions and help prevent their progression towards more severe stages.

References

  • 1.Blaha MJ, Bansal S, Rouf R, Golden SH, Blumenthal RS, Defilippis APA. Practical „ABCDE” Approach to the Metabolic Syndrome. Mayo Clin Proc. 2008;83(8):932–41. 10.1016/S0025-6196(11)60770-2 [DOI] [PubMed] [Google Scholar]
  • 2.Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults . Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–97. 10.1001/jama.285.19.2486 [DOI] [PubMed] [Google Scholar]
  • 3.Deen D. Metabolic Syndrome: Time for Action. Am Fam Physician. 2004;69(12):2875–82. [PubMed] [Google Scholar]
  • 4.Grundy SM, Cleeman J, Daniels SR, Donato KA, Eckel R, Franklin BA, et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–52. 10.1161/CIRCULATIONAHA.105.169404 [DOI] [PubMed] [Google Scholar]
  • 5.Levy M, Koeppen B, Stanton B. Berne & Levy Principles of Physiology. St Louis: Mosby. 2009. [Google Scholar]
  • 6.Hall J, Guyton A. Guyton and Hall Textbook of Medical Physiology. Philadelphia: Elsevier. 2016. [Google Scholar]
  • 7.Robinson RW, Demirel M, LeBeau RJ. Natural history of cerebral thrombosis: 9–19 years follow-up. J Chronic Dis. 1968;21(4):221–30. 10.1016/0021-9681(68)90059-3 [DOI] [PubMed] [Google Scholar]
  • 8.Faught WE, Mattos MA, van Bemmelen PS, Hodgson KJ, Barkmeier LD, Ramsey DS, et al. Color-flow duplex scanning of carotid arteries: New velocity criteria based on receiver operator characteristic analysis for threshold stenoses used in the symptomatic and asymptomatic carotid trials. J Vasc Surg. 1994;19(5):818–27. 10.1016/S0741-5214(94)70006-0 [DOI] [PubMed] [Google Scholar]
  • 9.Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC, et al. Carotid Atherosclerosis and Coronary Heart Disease in the Metabolic Syndrome: Prospective data from the Bruneck Study. Diabetes Care. 2003;26(4):1251–7. 10.2337/diacare.26.4.1251 [DOI] [PubMed] [Google Scholar]
  • 10.Ballantyne CM, Hoogeveen RC, McNeill AM, Heiss G, Schmidt MI, Duncan BB, et al. Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study. Int J Obes (Lond). 2008;32(Suppl 2):S21–4. 10.1038/ijo.2008.31 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Samaržija K, Milošević P, Jurjević Z, Erdeljac E. Comparison of carotid stenosis grading by CT angiography and Doppler ultrasonography: How the statistical methods applied influence the results. Acta Clin Croat. 2022;60(3):457–66. 10.20471/acc.2021.60.03.17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2010;375(9710):181–3. 10.1016/S0140-6736(09)61794-3 [DOI] [PubMed] [Google Scholar]

Articles from Acta Clinica Croatica are provided here courtesy of Sestre Milosrdnice University Hospital Center

RESOURCES